Global Healthcare Analytical Testing Services Overview
Healthcare analytical testing services market size will grow from USD 6.5Bn in 2022 to USD 19.4Bn by 2032, at 11.5% CAGR growth.
Material testing is the term used to describe Healthcare Analytical Testing Services. Healthcare Analytical Testing Services are used to verify product quality and purity. It also includes an examination of contaminants that might contaminate the items throughout production or the early stages of product development. Bioanalytical testing devices are used to identify pharmaceuticals and their metabolites in biological matrices. These services are extensively employed in the production of medical equipment, pharmaceuticals, biotechnology, and drugs, which will further fuel the market expansion for Healthcare Analytical Testing Services.
The increase in adoption of full-time R&D outsourcing contracts is expected to boost the global Healthcare Analytical Testing Services market. Biopharmaceutical associations are increasingly outsourcing analytical testing services in order to boost their profit margins, shorten the time needed for product and process validation, and prevent significant capital investment. This has also become a major contribution to the Healthcare Analytical Testing Services Market's growth.
|
Attributes |
Details |
|
Healthcare Analytical Testing Services Market Value (2022) |
US$ 6.5Bn |
|
Healthcare Analytical Testing Services Market Projected Value (2032) |
US$ 19.4Bn |
|
Healthcare Analytical Testing Services Market CAGR (2022 – 2032) |
11.5% |
Global Healthcare Analytical Testing Services Dynamics
Growing focus on analytical testing of biologics and biosimilars
The introduction of biosimilars and biologics represents one of the most promising new therapeutic areas, and they create the need for more rapid and sensitive analytical techniques, which are more important in the pharmaceutical market for the growth of the Healthcare Analytical Testing Services Market.
For instance, in 2021, according to a US FDA report, the Centre for Drug Evaluation and Research (CDER) approved 50 new drugs either as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under the Biologics License Application (BLAs). Many of the products contain active moieties that had not been previously approved by FDA. Some drugs are characterized as NMEs that are used for administrative purposes, but nonetheless contains active moieties that are closely related to the active moieties in products that FDA has previously approved.
Rise in the R&D investments in the pharmaceutical and biopharmaceutical industry
R&D investments in the pharmaceutical and biopharmaceutical industries are one of the major factors driving the growth of Healthcare Analytical Testing Services. Market due to its benefits, such as bringing new and improved treatments to market, broadening the product lines, and increasing revenue and profitability.
For instance, in 2019, PhRMA member companies invested 83 billion U.S. dollars in research and development (R&D) by making biopharmaceutical industry the highest level of investment on record. PhRMA member companies have invested a grand total of nearly $1 trillion over the last few decades in the research and development of new treatments.
Restrains:
High cost of healthcare analytical testing services obstructs the growth of target market. Expensive equipment and maintenance costs, tight reagent usage standards, and a lack of expertise are some key factors that would hamper the growth of the Healthcare Analytical Testing Services.
Global Healthcare Analytical Testing Services Segmentation
Healthcare Analytical Testing Services Market is segmented based on Service Type, End-User and Region.
Service Type Insight
On the basis of Service Type, the Healthcare Analytical Testing Services Market is segmented into Bioanalytical Testing Services, Physical Characterization Services, Method Development and Validation, Raw Material Testing, and Others (Testing Services, Stability Testing, Microbial Testing, and Environmental Monitoring). The Bioanalytical Testing Services segment is expected to dominate the target market growth due to the increasing number of drugs in the biopharmaceutical pipeline and the growing biopharmaceutical industry across the globe.
End-User Insights
On the basis of End-User, the Healthcare Analytical Testing Services Market is segmented into Pharmaceutical and Biotechnology Companies, Medical Device Companies, and Contract Research Organizations. Pharmaceutical and Biotechnology Companies are expected to dominate the target market growth due to rising outsourcing of analytical testing services by pharmaceutical and biopharmaceutical companies to boost profit margins, avoid high capital expenditures, and reduce the time required to validate the process and product.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
On the basis of region, the Healthcare Analytical Testing Services Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to factors such as the availability of advanced, well-developed healthcare infrastructure in the region. It is projected that the need for Healthcare Analytical Testing Services in the region will expand due to the region having the largest clinical trial industry globally.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022 – 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Service Type - Bioanalytical Testing Services, Physical Characterization Services, Method Development And Validation, Raw Material Testing, and Others (Testing Services, Stability Testing, Microbial Testing, and Environmental Monitoring. By End-User - Pharmaceutical Companies And Biotechnology Companies, Medical Device Companies, and Contract Research Organizations |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Healthcare Analytical Testing Services Market report based on basis of Service Type, End-user, and Region:
Healthcare Analytical Testing Services Market, By Service Type:
- Bioanalytical Testing Services
- Physical Characterization Services
- Method Development and Validation
- Raw Material Testing
- Others (Testing Services, Stability Testing, Microbial Testing, and Environmental Monitoring)
Healthcare Analytical Testing Services Market, By End-User:
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Contract Research Organizations
Healthcare Analytical Testing Services Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Recent Development:
- In March 2022, Thermofisher (US) collaborated with Symphogen (an affiliate of and the antibody center of excellence within the international pharmaceutical company Server) to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins. Symphogen has adopted a new and innovative instrument and a software to improve data quality and a way of method to develop, test and routinely implement platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.
- In April 2021, Charles River International, Inc., announced the acquisition of Retrogenix Ltd., an early-stage contract research organization (CRO) that provides bioanalytical services utilizing its proprietary cell microarray technology. Retrogenix offers cell microarray services for target receptor discovery, off-target profiling, and target deconvolution on a variety of innovative medicines, including biologics, cell therapies, and small compounds.
- In December 2021, Alcami Corp., a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO) announced complete acquisition of Masy Systems Inc., a preferred provider of cGMP Bio storage and pharma support services. The acquisition further provides complementary service offerings and further reinforces Alcami's ambitious growth and expansion initiatives.
Global Healthcare Analytical Testing Services Key Players
The key players operating the Healthcare Analytical Testing Services Market includes, Eurofins Scientific SE, WuXi PharmaTech (Cayman) Inc, Charles River Laboratories, Inc., Almac Group Limited, Everly Well, Inc., Exova Group Limited, Pharmaceutical Product Development, LLC, Source BioScience Plc, Anabiotec NV, and Intertek Group plc.
Global Healthcare Analytical Testing Services Company Profile
- Eurofins Scientific SE*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- WuXi PharmaTech (Cayman) Inc.
- Charles River Laboratories, Inc.
- Almac Group Limited
- Everly Well, Inc
- Exova Group Limited
- Pharmaceutical Product Development, LLC
- Source BioScience Plc
- Anabiotec NV
- Intertek Group plc.
“*” marked represents similar segmentation in other categories in the respective section
Global Healthcare Analytical Testing Services Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Service Type
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Healthcare Analytical Testing Services Market, By Service Type, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Bioanalytical Testing Services
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Physical Characterization Services
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Method Development and Validation
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Raw Material Testing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Others (Batch Release Testing Services, Stability Testing, Microbial Testing, and Environmental Monitoring)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Healthcare Analytical Testing Services Market, By End-User, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Pharmaceutical Companies And Biotechnology Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Medical Device Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Contract Research Organizations
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Healthcare Analytical Testing Services Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Service Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Service Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Service Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Service Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Service Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Overview
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Eurofins Scientific SE
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- WuXi PharmaTech (Cayman) Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Charles River Laboratories, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Almac Group Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Everly Well, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Exova Group Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Pharmaceutical Product Development, LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Source BioScience Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Anabiotec NV
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Intertek Group plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Eurofins Scientific SE
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
Global Healthcare Analytical Testing Services Highlights
FAQs
The Healthcare Analytical Testing Services Market is segmented into Service Type, End-User and Region.
Healthcare Analytical Testing Services Market is driven by factors like growing focus on analytical testing of biologics and biosimilars and rise in the R&D investments in the pharmaceutical and biopharmaceutical industry.
By region, the Healthcare Analytical Testing Services Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Healthcare Analytical Testing Services Market includes Eurofins Scientific SE, WuXi PharmaTech (Cayman) Inc, Charles River Laboratories, Inc., Almac Group Limited, Everly Well, Inc., Exova Group Limited, Pharmaceutical Product Development, LLC, Source BioScience Plc, Anabiotec NV, and Intertek Group plc.
Healthcare Analytical Testing Services Market accounted for US$ 6.5 billion in 2022 and is estimated to be US$ 19.4 billion by 2032 and is anticipated to register a CAGR of 11.5%.